Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

'Teach-In' for Equity Analysts

27 Nov 2012 07:00

RNS Number : 0496S
WANdisco Plc
27 November 2012
Ā 



27 November 2012

Ā 

WANdisco plc

Ā 

("WANdisco" or the "Company")

Ā 

'Teach-In' for Equity Analysts

Ā 

London, UK - WANdisco (LSE: WAND), a leading provider of enterprise high availability software for Big Data and software development, will today host a 'Teach-In' event for sell side equity analysts.

Ā 

A series of presentations will be given by the Group's senior management team. No new material trading or financial information will be disclosed.

Ā 

For details of today's event please contact FTI Consulting on the numbers below.

Ā 

Ā 

About WANdisco

WANdisco (LSE: WAND) is aĀ leading provider of enterprise high availability software. The company's products include: uberSVN - the new open ALM platform for Subversion, Subversion MultiSite, Subversion Access Control and Subversion Clustering. Fortune Global 1000 companies such as AT&T, Intel, Honda, Nokia, Juniper Networks and Motorola rely on WANdisco's Subversion solutions for enterprise-class performance, scalability and 24-by-7 availability. A recent Forrester Total Economic Impact (TEI) study of WANdisco's Subversion MultiSite revealed a 167% return on investment with a nine-month payback period. Subversion is recognized by Forrester as the sole leader in the Standalone Software Configuration Management (SCM) category. For more information, please visit us at: http://www.wandisco.com.

Ā 

Ā 

For further information please contact:

Ā 

WANdisco plc:

David Richards, Chairman and Chief Executive Officer

via FTI Consulting

Nick Parker, Chief Financial Officer

FTI Consulting:

+44 (0)20 7831 3113

Matt Dixon / Sophie McMillan / Jon Snowball

Panmure Gordon & Co.

+44 (0)20 7886 2500

Fred Walsh / Giles Stewart (Corporate Finance)

Adam Pollock, Charles Leigh-Pemberton (Corporate Broking)

Ā 

Ā 

Ends

Ā 

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
MSCBKADDFBDDCDB
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.